PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
Detalii Canal
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support c...
Episoade Recente
164 episoade
William D. Tap, MD - Achieving Disease Control in TGCT: Critical Steps For Integrating Evidence-Based Care With CSF1R Inhibitors
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Manmeet S. Ahluwalia, MD, MBA, FASCO - Next-Generation Solutions to Optimize Glioma Care: Applying The Latest Evidence on Molecularly Targeted Therapies in IDH-Mutant Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Jonathan W. Goldman, MD - Addressing un-MET Needs in NSCLC: Elevating MET-Targeting Options for Patients With a Poor Prognosis
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Geoffrey Ku, MD - Turning the Tide in Gastric Cancer Management: Integrating Modern Systemic Therapies Across the Disease Continuum for Community-Based Clinicians
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Ciro Rinaldi, MD, PhD - Elevating Total Care for PV and ET: From Diagnostic Precision to Patient-Centred Innovation
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. Konstanze Döhner - The Practicalities of Personalised Therapy in AML: The Who, How, When, and Why of Treating IDH1-Mutated Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Karen C. Daily, D.O. - RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence/Persistence
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Yelena Y. Janjigian, MD*, Siva Raja, MD, PhD, FACS - Critical Conversations for Surgeons and Oncologists in Resectable Gastric/GEJ Cancer: Expert Guidance on Integrating Rapidly Evolving Evidence for Immunotherapy Platforms
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Nicolas Girard, MD, PhD / Pasi A. Jänne, MD, PhD - Making Precision Decisions for Patients With EGFRm NSCLC: Success Strategies With Targeted Options, Potent Combinations, and Emerging Agents
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Nikhil I. Khushalani, MD - The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Paolo Ghia, MD, PhD - The Clock Strikes Innovation in CLL: Upfront Care With Newer, Time-Limited BTKi Combinations
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Sanjay Popat, FRCP, PhD - The Earlier the Better in Lung Cancer: Multispecialty Guidance on Screening, Diagnosis and Management of Resectable NSCLC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Komal Jhaveri, MD, FACP - Changing the Scenery in ER+, HER2- MBC With New Oral SERDs and Combinations: Foundations, Evidence, and Practicalities
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Nitin Jain, MD - Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Krish Patel, MD - Mapping Therapeutic Directions in DLBCL: Team Strategies for Prognostic Assessment and Implications for Targeted Therapy and Other Innovative Options
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Haley A. Moss, MD, MBA / Angeles Alvarez Secord, MD, MHSc - Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Tanios Bekaii-Saab, MD - Playing the Right Sequence in mCRC: Practical Strategies for Integrating Multi-Kinase Inhibitors in Later Lines of Therapy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Grzegorz (Greg) S. Nowakowski, MD, FASCO - Raising Frontline Expectations in DLBCL: Principles for Refining Upfront Treatment and Addressing Unmet Needs With Modern Antibody-Based Combinations
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Naval Daver, MD, Ghayas Issa, MD - All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Donna D. Catamero, ANP-BC, OCN, CCRC / Joshua Richter, MD, FACP - At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Ghassan Abou-Alfa, MD, JD, MBA, PhD (hc) - Immune to the Impossible in Hepatobiliary Malignancies: Expert Insights on Breakthrough Innovations for Immunotherapy Platforms in Advanced-Stage Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Jonathan L. Kaufman, MD - The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Sagar Lonial, MD, FACP - 4x4 in Multiple Myeloma: Maintaining Momentum for Delivering Innovative Care in Newly Diagnosed and Relapsed Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Samuel Cytryn, MD, Yelena Y. Janjigian, MD* - Achieving Excellence in Gastric/GEJ Cancer Care: Multidisciplinary Guidance on Immunotherapy Platforms in Resectable Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. Peter R. Galle - Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
"Prof. Wojciech Jurczak, MD, PhD - Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience"
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Heinz-Josef Lenz, MD, FACP - Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Tina Cascone, MD, PhD / Heather A. Wakelee, MD, FASCO - Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. Patrick Schöffski, MPH / Breelyn A. Wilky, MD - Patient-Centric Frameworks in Desmoid Tumors: Integrating Emerging Science on Gamma Secretase Inhibitors for Progressive Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...